高级检索
前列腺素E_2和E_1治疗性中期妊娠引产513例的临床观察[J]. 中国药科大学学报, 1985, (2): 38-41.
引用本文: 前列腺素E_2和E_1治疗性中期妊娠引产513例的临床观察[J]. 中国药科大学学报, 1985, (2): 38-41.
CLINICAL STUDY ON THERAPEUTIC ABORION BY PGE_2 AND PGE_1 OF 513 SUBJECTS[J]. Journal of China Pharmaceutical University, 1985, (2): 38-41.
Citation: CLINICAL STUDY ON THERAPEUTIC ABORION BY PGE_2 AND PGE_1 OF 513 SUBJECTS[J]. Journal of China Pharmaceutical University, 1985, (2): 38-41.

前列腺素E_2和E_1治疗性中期妊娠引产513例的临床观察

CLINICAL STUDY ON THERAPEUTIC ABORION BY PGE_2 AND PGE_1 OF 513 SUBJECTS

  • 摘要: 本文采用宫腔内羊膜囊外给药法对自制PGE_2和PGE_1进行治疗性中期引产227例和237例,成功率分别为98.2%和96.2%。其中完全流产者均占90%。平均总剂量分别为1.6mg和3.3mg;平均总产程分别为12小时和21小时;平均出血量分别为47ml和51ml。出现轻度消化道副反应者分别为26%和38%。感染率低,流产后康复快,是一类值得推荐的中期妊娠引产药物。PGE_2试用于临床抗早早孕也初见成效。49例中有效者为35例,其中完全流产25例,不完全流产10例,总有效率为71.4%。

     

    Abstract: The intrauterine-extraaminiotic administration of PGE_2 and PGE_1, showed a definite effect in the treatment of 227 and 237 subjects for the therapeutic abortion of mid-trimester pregnancy. Abortion was successful in 98.4% and 96.3% respectively, and comp

     

/

返回文章
返回